OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis. by Gwyer Findlay, E, Danks, L, Madden, J, Cavanagh, M, McNamee, K, McCann, F, Snelgrove, R, Shaw, S, Feldmann, M, Taylor, P, Horwood, N, Hussell, T

Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT). by MacDonald, TM, Hawkey, CJ, Ford, I, McMurray, JJV, Scheiman, JM, Hallas, J, Findlay, E, Grobbee, DE, Hobbs, FDR, Ralston, SH, Reid, DM, Walters, MR, Webster, J, Ruschitzka, F, Ritchie, LD, Perez-Gutthann, S, Connolly, E, Greenlaw, N, Wilson, A, Wei, L, Mackenzie, IS

Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: A double-blind randomized controlled trial by MacDonald, TM, Williams, B, Webb, DJ, Morant, S, Caulfield, M, Cruickshank, JK, Ford, I, Sever, P, Mackenzie, IS, Padmanabhan, S, McCann, GP, Salsbury, J, McInnes, G, Brown, MJ, Schumann, A, Helmy, J, Maniero, C, Burton, TJ, Quinn, U, Hobbs, L, Palmer, J, Collier, D, Markandu, N, Saxena, M, Zak, A, Enobakhare, E, Mackay, J, Thom, SA, Coughlan, C, McGinnis, AR, Findlay, E, Stanley, AG, White, C, Lacy, P, Gardiner-Hill, CJ, Nazir, S, McInnes, GT, Muir, S, McCallum, L, Melville, V, MacIntyre, IM, Brown, R, Simon, R, Soran, H, Kwok, S, Balakrishnan, K, Hobbs, R, Iles, R, Myint, KS, Cannon, J, Hood, S, Rutkowski, K, Webb, A, Martin, U, Kean, S, Wilson, R, Papworth, R